🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 12 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/07/2017 35,55 35,55 33,45 33,89 -3,03% 5,91% 1.816.900
17/07/2017 35,50 36,15 34,83 34,95 -0,85% 3,72% 1.408.500
14/07/2017 35,29 35,45 34,99 35,25 +0,00% 1,30% 888.300
13/07/2017 34,45 35,63 33,72 35,25 +1,73% 5,54% 1.240.100
12/07/2017 34,46 35,11 34,08 34,65 +1,35% 2,99% 1.220.500
11/07/2017 34,48 34,77 33,75 34,19 +0,41% 2,96% 761.500
10/07/2017 34,38 34,85 33,87 34,05 -0,90% 2,85% 646.400
07/07/2017 34,19 34,58 33,61 34,36 +0,88% 2,84% 962.100
06/07/2017 35,00 35,48 33,86 34,06 -3,40% 4,63% 1.264.500
05/07/2017 34,91 35,88 34,09 35,26 +1,18% 5,13% 1.518.300
03/07/2017 33,81 35,04 33,64 34,85 +3,38% 4,14% 656.000
30/06/2017 33,23 33,96 33,14 33,71 +1,02% 2,47% 773.300
29/06/2017 35,00 35,35 33,03 33,37 -1,45% 6,63% 2.719.500
28/06/2017 33,25 34,10 32,36 33,86 +2,51% 5,23% 1.208.200
27/06/2017 34,52 35,06 32,96 33,03 -4,68% 6,08% 1.451.700
26/06/2017 35,14 35,40 34,37 34,65 -1,06% 2,93% 1.037.700
23/06/2017 35,36 35,43 34,28 35,02 -1,30% 3,25% 2.047.700
22/06/2017 36,05 36,80 35,32 35,48 +0,31% 4,11% 2.322.000
21/06/2017 33,83 35,49 33,56 35,37 +5,55% 5,70% 1.904.900
20/06/2017 33,26 34,39 33,15 33,51 +0,60% 3,73% 1.439.900
19/06/2017 32,53 33,79 32,49 33,31 +2,78% 4,00% 1.309.600
16/06/2017 32,13 32,65 31,80 32,41 +0,09% 2,65% 1.292.800
15/06/2017 32,95 33,81 32,15 32,38 -2,29% 5,04% 970.600
14/06/2017 32,96 34,64 32,76 33,14 +0,94% 5,70% 2.074.800
13/06/2017 31,84 32,85 31,23 32,83 +2,75% 5,09% 1.407.100
12/06/2017 31,47 32,09 30,09 31,95 +1,53% 6,36% 1.180.300
09/06/2017 31,55 33,11 31,23 31,47 -0,25% 5,96% 2.059.400
08/06/2017 31,91 31,91 31,27 31,55 +0,48% 2,01% 607.200
07/06/2017 31,37 32,15 31,15 31,40 -0,32% 3,19% 973.300
06/06/2017 31,38 32,27 31,01 31,50 +0,19% 4,02% 870.800